Royal Bank Of Canada Vertex Pharmaceuticals Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 1,567,636 shares of VRTX stock, worth $640 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,567,636

Previous 1,681,600 6.78%

Holding current value

$640 Million

Previous $788 Million 7.5%

% of portfolio

0.15%

Previous 0.19%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $52.4 Million - $57.6 Million	-113,964 Reduced 6.78%	1,567,636 $729 Million
Q2 2024 Nov 06, 2024	SELL	$392.81 - $485.53 $15.8 Million - $19.5 Million	-40,189 Reduced 2.33%	1,681,600 $788 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $71.3 Million - $88.1 Million	181,458 Added 11.78%	1,721,789 $807 Million
Q1 2024 Nov 05, 2024	SELL	$407.69 - $446.08 $85.9 Million - $93.9 Million	-210,585 Reduced 12.23%	1,511,204 $632 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $35 Million - $38.3 Million	85,859 Added 5.9%	1,540,331 $644 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $76.9 Million - $92.1 Million	224,276 Added 18.23%	1,454,472 $592 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $4.27 Million - $4.58 Million	12,630 Added 1.04%	1,230,196 $428 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $28.9 Million - $32.3 Million	91,890 Added 8.16%	1,217,566 $428 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $46.8 Million - $53.4 Million	165,244 Added 17.21%	1,125,676 $355 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $10.6 Million - $12 Million	37,192 Added 4.03%	960,432 $277 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $10.4 Million - $11.6 Million	38,005 Added 4.29%	923,240 $267 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $10.6 Million - $13.2 Million	45,140 Added 5.37%	885,235 $249 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $30.2 Million - $35.6 Million	136,396 Added 19.38%	840,095 $219 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $13.6 Million - $17.2 Million	-76,891 Reduced 9.85%	703,699 $155 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $52.9 Million - $59.2 Million	-291,551 Reduced 27.19%	780,590 $142 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $201 Million - $237 Million	1,072,141 New	1,072,141 $216 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Vertex Pharmaceuticals Inc Transaction History